Jul 29th, 2025
RFK Jr. Hints FDA Approval of Psychedelic Therapy Hope
RFK Jr. earlier this month said he could envision approval for psychedelic drugs as treatment for depression and trauma if clinical studies have been conducted. Kabir Nath, CEO of Compass Pathways, makers of synthetic psilocybin told Bloomberg Businessweek Daily, his company is conducting clinical studies for the treatment of depression.
